The General Hospital Corporation;Children's Medical Center Corporation
发明人:
申请号:
EP12767300.2
公开号:
EP2694660B1
申请日:
2012.03.12
申请国别(地区):
EP
年份:
2018
代理人:
摘要:
Aspects of the invention described herein relate to synthetic, modified RNAs and their use in vivo to modulate gene expression. Aspects of the invention further relate to the use of these synthetic, modified RNAs in myocytes, cardiomyoctes, and tumors.